Azithromycin 500 mg
Product Description
Ethypharm
-
Country/Region:France
-
Founded:1977
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
Categories
Specifications
Ethypharm
-
Country/Region:France
-
Founded:1977
-
On CPHI since:2015
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
More Products from Ethypharm (57)
-
Product Adrenaline (Epinephrine) Solution for Injection
Adrenaline Solution for Injection is a fast-acting emergency medicine used for the treatment of life-threatening conditions such as anaphylaxis and cardiac arrest. It contains epinephrine, a potent sympathomimetic agent that stimulates alpha and beta-adrenergic receptors, resulting in rapid vasoconstrictio... -
Product Alprostadil 20 μg
Symptomatic treatment of peripheral occlusiveartery disease (PAD) in Leriche-Fontaine stages IIIand IV, excluding patients who are candidates foramputations -
Product Aprepitant
Prevention of nausea and vomiting associatedwith highly and moderately emetogenic cancerchemotherapy -
Product Argatroban Solution for Infusion
Argatroban is a direct thrombin inhibitor used for anticoagulation in patients with heparin-induced thrombocytopenia type II (HIT II). It is administered by continuous IV infusion and offers rapid, predictable anticoagulant effects. Available as a ready-to-use solution or a concentrate for dilution, it pro... -
Product Atosiban Acetate
Delay imminent preterm birth -
Product Atropine Sulfate
To reduce salivary and bronchial secretion.To treat bradycardia induced by drugs or toxicsubstances and acute myocardial infarction -
Product Buprenorphine / Naloxone Sublingual Tablets
Buprenorphine/Naloxone Sublingual Tablets are indicated for the treatment of opioid dependence as part of a comprehensive medical, social, and psychological support program. The combination of buprenorphine, a partial opioid agonist, and naloxone, an opioid antagonist, is designed to reduce withdrawal symp... -
Product Buprenorphine Hydrochloride
Buprenorphine Oral Lyophilisate is a rapidly dispersing formulation designed for the treatment of opioid dependence as part of a comprehensive care program including medical, social, and psychological support. The product contains buprenorphine, a partial opioid agonist that helps reduce withdrawal symptom... -
Product Buprenorphine Hydrochloride Sublingual tablet
Substitution treatment for opioid drug dependence,within a framework of medical, social andpsychological treatment -
Product Caffeine Citrate 10 mg/ml
Treatment of apnoea of prematurity -
Product Calcium Folinate Hydrate
Calcium folinate rescue to reduce methotrexate/folic acid antagonist toxicity and manage overdose.In combination with 5-fluorouracil in cytotoxictherapy -
Product Captopril
Hypertension, Heart Failure, Myocardial Infarction,Type I Diabetic Nephropathy.Can be used alone and in combination with otherantihypertensive agents, especially thiazide diuretics
Ethypharm resources (1)
-
Brochure Product List 2026
This is a brochure consist of the product portfolio of Ethypharm.

